癌细胞
癌症
糖苷
细胞周期
信号转导
视网膜母细胞瘤
医学
细胞生物学
生物
生物化学
化学
立体化学
内科学
基因
作者
Xin Sun,Xiao-Wei Shi,Lei Han,Yi-Fan Zhang,Yang Xu,Yu-Cheng Lu
标识
DOI:10.5306/wjco.v16.i8.107490
摘要
, periplocin is an alpha cardiac glycoside with a steroid core and an unsaturated five-membered lactone ring structure. Periplocymarin is a secondary alpha cardiac glycoside, which is produced by removing one molecule of glucose from periplocin, and periplogenin is the glycosidic portion and the basic unit of periplocin and periplocymarin. These three cardiac glycosides, by virtue of their unique pharmacological activities and mechanisms of action, mediate signaling pathways, mainly the retinoblastoma and p53 signaling pathways, and regulate cell cycle proteins, thereby hindering the proliferation of cancer cells and altering the cell cycle process. These glycosides also regulate caspase proteins by mediating endogenous and exogenous pathways, thereby inducing the apoptosis of cancer cells. This minireview focuses on the inhibitory effects of periplocin, periplocymarin and periplogenin on cancer, and explores their potential antitumor mechanisms.
科研通智能强力驱动
Strongly Powered by AbleSci AI